Recently Acquired Blood-borne Virus Infections in Australian Deceased Organ Donors: Estimation of the Residual Risk of Unexpected Transmission.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
05
12
2022
accepted:
29
12
2022
entrez:
27
2
2023
pubmed:
28
2
2023
medline:
28
2
2023
Statut:
epublish
Résumé
Unexpected donor-derived infections of hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV are rare but important potential complications of deceased organ transplantation. The prevalence of recently acquired (yield) infections has not been previously described in a national cohort of Australian deceased organ donors. Donor yield infections are of particularly significance, as they can be used to gain insights in the incidence of disease in the donor pool and in turn, estimate the risk of unexpected disease transmission to recipients. We conducted a retrospective review of all patients who commenced workup for donation in Australia between 2014 and 2020. Yield cases were defined by having both unreactive serological screening for current or previous infection and reactive nucleic acid testing screening on initial and repeat testing. Incidence was calculated using a yield window estimate and residual risk using the incidence/window period model. The review identified only a single yield infection of HBV in 3724 persons who commenced donation workup. There were no yield cases of HIV or HCV. There were no yield infections in donors with increased viral risk behaviors. The prevalence of HBV, HCV, and HIV was 0.06% (0.01-0.22), 0.00% (0-0.11), and 0.00% (0-0.11), respectively. The residual risk of HBV was estimated to be 0.021% (0.001-0.119). The prevalence of recently acquired HBV, HCV, and HIV in Australians who commence workup for deceased donation is low. This novel application of yield-case-methodology has produced estimates of unexpected disease transmission which are modest, particularly when contrasted with local average waitlist mortality.
Identifiants
pubmed: 36845855
doi: 10.1097/TXD.0000000000001447
pmc: PMC9944344
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1447Informations de copyright
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Transpl Infect Dis. 2020 Dec;22(6):e13437
pubmed: 32767859
Transpl Int. 2022 May 03;35:10395
pubmed: 35592445
Transfusion. 2002 Oct;42(10):1365-72
pubmed: 12423522
Am J Transplant. 2011 Jun;11(6):1176-87
pubmed: 21366859
Transfusion. 2009 Aug;49(8):1609-20
pubmed: 19413732
Am J Transplant. 2011 Jun;11(6):1188-200
pubmed: 21401874
Transfusion. 2005 Feb;45(2):254-64
pubmed: 15660836
Clin Transplant. 2018 Oct;32(10):e13370
pubmed: 30080289
Med J Aust. 2019 Nov;211(9):414-420
pubmed: 31489635
Vox Sang. 2020 Apr;115(3):133-145
pubmed: 31960480
Transpl Int. 2008 Oct;21(10):936-41
pubmed: 18537922
Transfusion. 2016 Jun;56(6 Pt 2):1662-7
pubmed: 27060456
Pediatr Nephrol. 2019 Oct;34(10):1743-1751
pubmed: 31243535
Transfusion. 2019 Sep;59(9):2922-2930
pubmed: 31265759
Intern Med J. 2005 Oct;35(10):592-8
pubmed: 16207258
Transpl Infect Dis. 2021 Feb;23(1):e13458
pubmed: 32894634
Transplantation. 2017 Jul;101(7):1666-1669
pubmed: 28196048
Transfusion. 2019 Jan;59(1):267-276
pubmed: 30265757
MMWR Morb Mortal Wkly Rep. 2019 Jan 25;68(3):61-66
pubmed: 30677008
Am J Transplant. 2009 Aug;9(8):1929-35
pubmed: 19538493
Am J Transplant. 2019 Sep;19(9):2560-2569
pubmed: 30959569